Company intelligence / Profile preview

ExtriCARE

Norristown, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

ExtriCARE markets powered negative pressure wound therapy (NPWT) devices and dressing kits, including advanced hybrid NPWT systems for hospital and post-acute care settings. Its flagship devices—extriCARE 1000 and extriCARE 3000—aim to deliver flexible, portable therapy for improved clinical outcomes in wound healing.

Therapeutic areas: OtherDermatology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Alleva Medical

Beyond the preview

Go deeper on ExtriCARE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ExtriCARE.

Explore the full profile